As breakthrough drugs offer critical hope to patients, lawmakers should focus on shoring up the social safety net
commentary
As breakthrough drugs offer critical hope to patients, lawmakers should focus on shoring up the social safety net
Published
May 15, 2026 10:05AM (EDT)
Insurers frequently deny or delay cancer care to patients, including breakthrough immunotherapies like Keytruda (Shivansh Gupta/PA Images via Getty Images)
Secret drug pricing deals, a virtual AI cancer clinic, and other biotech news from The Readout
Merck built a wall of patents that keeps a cancer drug's price – and its profits – high. Hospitals often add to the cost for…
Drugmaker echoes president’s insistence that overseas health services fund new treatments
More than 5,000 shelved drug candidates were discontinued for business reasons, not safety ones. A new push aims to match them…
New laws will let hospitals create personalised treatments on-site, cutting delays and improving outcomes for critically ill…
Previously blocked cancer treatment could get green light under health shake-up plans
